Intra-uterine growth in infants of diabetic mothers

Insights

Infants of poorly controlled diabetic mothers had higher birth weights and different body proportions compared to well-controlled cases. Ear hairiness may indicate maternal diabetes in newborns.

Area of Science:

  • Neonatal studies
  • Maternal-fetal medicine
  • Endocrinology

Background:

  • Maternal diabetes can impact fetal growth and development.
  • Understanding these effects is crucial for neonatal care and outcomes.
  • Poor glycemic control in diabetic pregnancies poses risks.

Purpose of the Study:

  • To compare anthropometric measurements and body proportions of infants born to mothers with well-controlled versus poorly controlled diabetes.
  • To identify potential clinical signs indicative of a diabetic mother.

Main Methods:

  • Comparison of birth weight, length, and head circumference between two groups of infants.
  • Analysis of weight/length and head circumference/weight ratios.
  • Observation for specific physical characteristics like ear hairiness.

Main Results:

  • Infants of poorly controlled diabetic mothers were significantly heavier with altered weight/length and head circumference/weight ratios.
  • Infant length and head circumference/length ratios were appropriate for age in the poorly controlled group.
  • Normal size and proportions were observed in infants of well-controlled diabetic mothers.
  • Hairiness of the ear (pinna) was present in infants from both groups.

Conclusions:

  • Poorly controlled maternal diabetes leads to distinct patterns in infant size and body proportions.
  • Ear hairiness in newborns may serve as a useful clinical indicator for identifying infants of diabetic mothers.
  • Optimizing glycemic control during pregnancy is essential for normal fetal development.

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...